Earnings calls

Wockhardt concall ledger

Every earnings call for WOCKPHARMA — management tone, guidance, KPIs and promise tracking, quarter by quarter.

WOCKPHARMA · 2 transcripts · Healthcare · latest Q4 FY25

Q4 FY25Published 05 Jun 2025Call held 05 Jun 2025

WOCKPHARMA Q4 FY25 Earnings Call Transcript & Analysis

Revenue₹3,033 cr+5% YoYEBITDA₹418 cr+67% YoYEBITDA Margin14%Net Debt₹64 cr−93% YoY

Revenue ₹3,033 cr (+5% YoY); EBITDA ₹418 cr (+67% YoY); EBITDA Margin 14%. Annual Revenue reached ₹3,033 crores, representing a 5% YoY growth.

Q3 FY23Published 21 Feb 2023Call held 21 Feb 2023

Revenue₹699 crEBITDA₹59 cr

Revenue ₹699 cr; EBITDA ₹59 cr. Revenue grew to ₹699 crores in Q3 FY23, representing a 20% increase over Q1 FY23.